Benign prostatic hyperplasia is a state of the nature rather than a disease.
It affects mainly men over 50 years and represents a public health problem. A literature review on the therapeutic management of benign prostatic hyperplasia was carried out from a selection of publications with the highest level of evidence. Medical treatment is based on herbal medicine, alpha-blockers and 5-alpha-reductase inhibitors. Surgical treatment is used in case of complications or failure of medical management. Surgical options are numerous. Transurethral prostate resection and prostate adenomectomy are the most usual procedures. Due to their significant morbidity, other less invasive procedures have recently been developed. The choice of treatment will depend on prostate volume and anatomy and patient's comorbidities.
Written by:
Lahlaidi K, Ariane MM, Fontaine E. Are you the author?
Service d'urologie, hôpital européen Georges-Pompidou, AP-HP, 20, rue Leblanc, 75015 Paris, France.
Reference: Rev Med Interne. 2013 Nov 18. pii: S0248-8663(13)00686-3.
doi: 10.1016/j.revmed.2013.10.007
PubMed Abstract
PMID: 24262410
Article in French.
